1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Asensus Surgical, Inc.US flagNew York Stock Exchange Arca
0.35
USD
+0.00
- -
94.92MMarket Cap

Total Valuation

Asensus Surgical, Inc. carries a market capitalization of 94.92M, placing it among publicly traded companies globally. Its enterprise value stands at 101.20M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap94.92M
Enterprise Value101.20M

Share Statistics

Asensus Surgical, Inc. currently has 272.62M shares outstanding.

Shares Outstanding272.62M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 8.99, and the price-to-book ratio stands at -0.09.

PE RatioN/A
PS Ratio8.99
PB Ratio-0.09
P/TBV Ratio-7.18
P/FCF Ratio-1.58
P/OCF Ratio-1.56

Enterprise Valuation

EV / Sales10.27
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Asensus Surgical, Inc. maintains a current ratio of 0.49, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -180.39, indicating conservative leverage, while an interest coverage ratio of -210.17 demonstrates limited ability to service its debt obligations.

Current Ratio0.49
Quick Ratio0.21
Debt / Equity-180.39
Debt / EBITDA-0.30
Interest Coverage-210.17

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-143.40
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.58

Taxes

Income Tax356,000.00
Effective Tax RateN/A

Stock Price Statistics

Asensus Surgical, Inc.'s stock has gained approximately 21.0087% over the past 52 weeks. The 50-day moving average sits at 0.33, while the 200-day moving average is 0.29.

Beta (5Y)N/A
52-Week Price Change21.0087%
50-Day Moving Average0.33
200-Day Moving Average0.29
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Asensus Surgical, Inc. generated 9.85M in revenue and converted that into -83.80M in net income, yielding earnings per share of -0.32. EBITDA reached -67.47M, while operating income came in at -71.22M.

Revenue9.85M
Gross Profit-3.00M
Operating Income-71.22M
Pretax Income-83.44M
Net Income-83.80M
EBITDA-67.47M
EBIT-71.22M
Earnings Per Share (EPS)-0.32

Balance Sheet

Asensus Surgical, Inc. holds 7.78M in cash and equivalents against 20.43M in total debt, resulting in a net debt position of 7.53M. Total book value stands at -987.34M, with working capital of -20.48M providing operational flexibility.

Cash & Cash Equivalents7.78M
Total Debt20.43M
Net Debt7.53M
Equity (Book Value)-987.34M
Book Value Per Share-3.71
Working Capital-20.48M

Cash Flow

Asensus Surgical, Inc. produced -56.65M in operating cash flow over the past twelve months. After subtracting -506,000.00 in capital expenditures, free cash flow totaled -57.16M - equivalent to -0.21 per share.

Operating Cash Flow-56.65M
Capital Expenditures-506,000.00
Free Cash Flow-57.16M
FCF Per Share-0.21

Margins

Asensus Surgical, Inc. operates with a gross margin of -30.45, reflecting its pricing power and cost economics. The operating margin of -723.08 and net profit margin of -850.75 provide insight into operational efficiency.

Gross Margin-30.45
Operating Margin-723.08
Pretax Margin-847.14
Profit Margin-850.75
EBITDA Margin-684.93

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-29.14
FCF Yield-63.40

Stock Splits

Asensus Surgical, Inc.'s most recent stock split took place on December 12, 2019 with a 13:1 split ratio.

Last Split Date12/12/2019
Split Ratio13:1

Scores

Asensus Surgical, Inc. posts an Altman Z-Score of -42.48, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-42.48